Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Pivotal (Spain) | Researchclopedia

Back to institutions

Pivotal (Spain)

Madridcompany

68

Works

7,658

Citations

21

h-index

Top Research Topics

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics

Top Researchers

Kris Gevaert VIB-UGent Center for Medical Biotechnology

631 works33,631 citationsh-index: 103

Recent Research

State of the art of the molecular hyperselection to guide treatment with anti-EGFR antibodies in RAS WT mCRC: implications for clinical practice and future perspectives

Pilar García‐Alfonso,Manuel Valladares‐Ayerbes,et al.

20254 citations

Lung Cancer Diagnosis and Treatment

Bladder and Urothelial Cancer Treatments

Urinary and Genital Oncology Studies

Prostate Cancer Treatment and Research

Colorectal Cancer Treatments and Studies

Cytokine Signaling Pathways and Interactions

Renal cell carcinoma treatment

Protein Tyrosine Phosphatases

Lung Cancer Research Studies

Óscar Juan City Of Hope National Medical Center

393 works8,598 citationsh-index: 39

Ana Drozdowskyj Instituto Oncológico Dr. Rosell

76 works7,590 citationsh-index: 20

Eva Muñoz Saint Louis University

128 works1,811 citationsh-index: 23

Victor Ruiz‐Rodado Madrid Institute for Advanced Studies

47 works939 citationsh-index: 17

Óscar Vidal Hospital Universitari i Politècnic La Fe

64 works657 citationsh-index: 11

Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study

Alejo Rodríguez‐Vida,Begoña P. Valderrama,et al.

20241 citations

Urinary Metabolic Distinction of Niemann–Pick Class 1 Disease through the Use of Subgroup Discovery

C. J. Carmona,M. Germán-Morales,et al.

20233 citations

Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

Niki Karachaliou,Jordi Codony‐Servat,et al.

20231 citations

Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study

Alejo Rodríguez‐Vida,Pablo Maroto,et al.

202213 citations

Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study

Andrés Poveda,Raquel López-Reig,et al.

202210 citations